Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Warrants for shorts
View:
Post by steamfitter on Dec 03, 2021 1:20pm

Warrants for shorts

They need the warrants to cover their naked shorts. Don't sell warrant drive the price up for stock
Comment by menoalittle on Dec 03, 2021 1:54pm
tradeable (2024) warrants have such miniscule volume they are plainly insignificant at this point.  (in other words, those that own them  ;^)  obviously have no intention of selling them.)  me thinks the stock is where the action is (and will be) for some time to come. next week will be rather interesting, to say the least...
Comment by valueman1 on Dec 03, 2021 4:04pm
Does anyone know the details of the 2024 warrants or where I can find info. Thanks in advance
Comment by Scorpio2 on Dec 03, 2021 4:15pm
there are 57,499,000 warrants at an exercise price of 0.35 CAD that expire August, 2022. We are currently in the money now.
Comment by Scorpio2 on Dec 03, 2021 4:16pm
sorry...fat finger. They expire August 22, 2024.
Comment by Rumpl3StiltSkin on Dec 03, 2021 4:21pm
The $$$ from those Aug 2024 warrants will come in handy to run the company then, yet by then they will be up to their armpits in Phase 2 GBM, NSCLC, etc.. They'd better have good partners or SP. :-)
Comment by patience69 on Dec 03, 2021 4:47pm
Honestly lets have a vote. How many people here think that Theralase will exist in Aug 2024. I for one don't. Frankly I have my doubts about August 2022
Comment by skys1 on Dec 03, 2021 5:00pm
I completely agree patience69, I have been saying this for a long time now.
Comment by 99942Apophis on Dec 03, 2021 5:25pm
Well I guess that could happen if it goes on sale for $199.99
Comment by CancerSlayer on Dec 03, 2021 5:31pm
  Agree about 2024, but I'd hate to see TLT sell itself short.  May behoove the company to at least await an FDA approval for NMIBC don't you think.  I need to accumulate more while the price is right : ).
Comment by Alamir1111 on Dec 03, 2021 6:05pm
yes tlt will be around 2024 You guys counting chicken before they hatched.
Comment by Johnandrose22 on Dec 03, 2021 6:27pm
You've been a community member since November, 21, 2021. Thanks for the profound insights. Time for bed.
Comment by Alamir1111 on Dec 03, 2021 6:42pm
yes son 6 years and over 600k sleep tight
Comment by gebremeskel on Dec 03, 2021 6:46pm
My Magic 8 ball says "Reply hazy, try again"
Comment by Mikee3003 on Dec 03, 2021 7:06pm
Hi Patiience - If Theralase no longer exists in 2022/2024 as you suggest we will not see full value of this remarkable, possibly historic anti-cancer therapy. Hopefully TLT (Roger) plays it right over the next few years. Let's hope they sign up numerous partnerships/licensing deals with several big pharmas making it difficult for a takeover. It's been said here many times that TLT is Roger ...more  
Comment by Alamir1111 on Dec 03, 2021 7:29pm
thanks Mike I agree with you 100%
Comment by langosta on Dec 03, 2021 8:47pm
Well Mikee your reply to Patience is very reasonable but let us not forget that amongst the Longs are many in an age group who may not be too eager for a further extended stay and would be satisfied with a reasonably generous reward in a not too distant future.  I'm within that age group and have held on for approx 8 years which I suppose is average for Longs in this stock..   ...more  
Comment by 99942Apophis on Dec 03, 2021 9:14pm
There are far too many large pharmaceutical companies in competition with each other, you know once one makes an offer the bidding war will ignite. It will be fierce, I'm sure Theralase is aware of this and could as suggested franchise out treatment through them so profits can still be maintained. Which direction this company takes one thing is assured is that the share price of this stock ...more  
Comment by robertshaw on Dec 03, 2021 9:33pm
Cancer cure franchise stores , like KFC, brilliant idea!
Comment by StevenBirch on Dec 03, 2021 10:02pm
Let's face it TLT will not be bought out while being a $0.36 stock. There will be some intermediate price it gets to before any offer is made and that's why I think we will see some bump before the next report. There are catalysts for that bump and with any further approval from the FDA a second and/or third Phase 1b trial will be announced. It is then that I think we are on the clock ...more  
Comment by Yajne on Dec 03, 2021 11:04pm
Great post SB, I fully agree. To add, if an early offer does emerge, I think TLT has already set the stage, with it's latest data, for a bidding war. There are several BF players that will be impacted more that others if/when TLT receives BTD abd ultimately gets AA from the FDA. I should have read your post first before responding the link jaro posted. Yes, TLD1433 will hopefully have ' ...more  
Comment by Mikee3003 on Dec 03, 2021 9:34pm
I hear you Langosta, I'm no spring chicken either and have held this stock for several years. I've ran through my head a few exit strategies that would have me cashing out my holdings as certain milestones are met, that would be my preference. On the other hand if big pharma comes around in 2022 with a $5 - $10 offer,  I may just smile and say thanks I'm out....you know the bird ...more  
Comment by gojotv! on Dec 04, 2021 11:57am
If some old timers are willing to sell at such stupid low prices, please do so when the sp gets to $5-10. I didn't hold all these years to cash out under Apple share prices. Not for the cure for cancer. To say nothing of the importance of establishing a major Pharma-Tech company here in Canada. Squandering an opportunity like this just because you're old is the kind of blinkered ...more  
Comment by Mikee3003 on Dec 04, 2021 2:03pm
Hey gojo, I like your thinking however at the end of the day it won't be us retail investors that decide the fate of TLT. As we progress and results come in as expected, the elephants (pension funds, mutual funds, money managers, investment banks etc) that account for 80% - 85% of the volume of shares traded on the major NA stock exchanges will become the major factor on how things play out ...more  
Comment by Infinity on Dec 03, 2021 7:57pm
Well,  I have no idea,  why you believe Theralase will not exist in 2024.  TLT is on the verge of getting BTD approval from FDA.   Once an application is made for  BTD, my understanding is that the whole process gets on priority and FDA will respond within 60 Days with a decision or atleast ask for more information from TLT on the clinical study data. That being said, ...more  
Comment by Alamir1111 on Dec 03, 2021 8:27pm
Comment by CancerSlayer on Dec 03, 2021 8:27pm
Will likely not exist in its current form in the next 1 to 2 years...think we're all on the same page.  
Comment by Alamir1111 on Dec 03, 2021 8:28pm
Comment by cashascars on Dec 03, 2021 8:31pm
While I agree with your thoughts that TLT has a great future and if they do this alone it would be the best for shareholders who want to stay with them all the way to building this empire around ACT PDT TLD1433 and all the other great compounds Sherri has been working on. I'm just not sure if Big Pharma will allow TLT to do all this while they watch their profits dwindling as TLT takes over ...more  
Comment by jicoop on Dec 04, 2021 10:35am
Good morning all, just sipping my morning coffee, and taking my first painkillers for the day, after procedure last week, like many have sid, this aging thing sucks, but from cathcing up on some posts of late, I am still a youg buck in comparison to many here, only being in my early 60's , so I'll zip it and stop complaining. Without getting to long winded, I will agree with cashascars ...more  
Comment by Alamir1111 on Dec 03, 2021 8:32pm
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250